Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Asia.
Interventions
OTHERNo treatment given
Subject will only fill out a questionaire when entering the observational study.
Sponsors
Novo Nordisk A/S
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit. * Patients willing to sign informed consent form.
Exclusion criteria
* Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of diabetic patients having diabetic nephropathy | at baseline visit/study start |
| Percentage of diabetic patients having dyslipidemia and hypertension | at baseline visit/study start |
| Percentage of diabetic patients having cardiovascular complications | at baseline visit/study start |
| Percentage of diabetic patients having peripheral vascular disease | at baseline visit/study start |
| Percentage of diabetic patients having diabetic eye complications | at baseline visit/study start |
| Mean age of onset of type 1 and 2 diabetes mellitus | at baseline visit/study start |
| Mean duration of treatment of type 2 DM | at baseline visit/study start |
| Percentage of patients on Insulin and OAD therapy | at baseline visit/study start |
| Mean duration of diabetes in type 1 and type 2 patients respectively | at baseline visit/study start |
| Mean FPG and PPG of diabetic patients | at baseline visit/study start |
| Mean HbA1c of diabetic patients | at baseline visit/study start |
| Percentage of diabetic patients with HbA1c target below or equal to 7.0%. | at baseline visit/study start |
| Percentage of diabetic patients with HbA1c target below or equal to 6.5%. | at baseline visit/study start |
Secondary
| Measure | Time frame |
|---|---|
| Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about HbA1c test and its goal, anti-diabetic treatment and barriers towards optimum diabetes control | at baseline visit/study start |
| Duration of diabetes associated with highest number of diabetic complications | at baseline visit/study start |
| Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy) | at baseline visit/study start |
| Patients' perception will be analysed through Patient questionnaire measuring:Psychological well-being, Quality of life and Patients' compliant to treatment | at baseline visit/study start |
Countries
Bangladesh
Outcome results
None listed